| 臺大學術典藏 |
2022-02-14T05:27:15Z |
Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan
|
Hsu M.-H.; Wang W.-L.; Chen T.-H.; Tai C.-M.; HSIU-PO WANG; Lee C.-T. |
| 臺大學術典藏 |
2022-02-14T05:27:15Z |
Deceleration capacity of heart rate variability as a predictor of sedation related hypotension
|
Tsai F.-F.; Liu C.-M.; HSIU-PO WANG; Yeh J.-R.; Fan S.-Z. |
| 臺大學術典藏 |
2022-02-14T05:27:15Z |
Transpancreatic biliary sphincterotomy for difficult biliary cannulation: Can it be better than other methods?
|
HSIU-PO WANG |
| 臺大學術典藏 |
2022-02-14T05:27:15Z |
Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma
|
Chuang P.-J.; HSIU-PO WANG; Lin Y.-J.; Chen C.-C.; Tien Y.-W.; Hsieh M.-S.; Yang S.-H.; Yen R.-F.; Ko C.-L.; Wu Y.-W.; Cheng M.-F. |
| 臺大學術典藏 |
2022-02-14T05:27:16Z |
Two novel protocols for cleaning residual simethicone and fluid in patient-ready duodenoscopes
|
Peng C.-L.; Liu T.-C.; HSIU-PO WANG; Chang W.-K. |
| 臺大學術典藏 |
2022-02-14T05:27:16Z |
Automatic segmentation of pancreatic tumors using deep learning on a video image of contrast-enhanced endoscopic ultrasound
|
Iwasa Y.; Iwashita T.; Takeuchi Y.; Ichikawa H.; Mita N.; Uemura S.; Shimizu M.; Kuo Y.-T.; HSIU-PO WANG; Hara T. |
| 臺大學術典藏 |
2022-02-14T05:27:16Z |
A clinically interpretable convolutional neural network for the real-time prediction of early squamous cell cancer of the esophagus: comparing diagnostic performance with a panel of expert European and Asian endoscopists
|
Everson M.A.; Garcia-Peraza-Herrera L.; HSIU-PO WANG; Lee C.-T.; Chung C.-S.; Hsieh P.-H.; Chen C.-C.; Tseng C.-H.; Hsu M.-H.; Vercauteren T.; Ourselin S.; Kashin S.; Bisschops R.; Pech O.; Lovat L.; Wang W.-L.; Haidry R.J. |
| 臺大學術典藏 |
2022-02-14T05:27:16Z |
The Asian Federation of Societies for Ultrasound in Medicine and Biology (AFSUMB) Guidelines for Contrast-Enhanced Endoscopic Ultrasound
|
Kitano M.; Yamashita Y.; Kamata K.; Ang T.L.; Imazu H.; Ohno E.; Hirooka Y.; Fusaroli P.; Seo D.-W.; Napoléon B.; Teoh A.Y.B.; Kim T.H.; Dietrich C.F.; HSIU-PO WANG; Kudo M.; Working group for the International Consensus Guidelines for Contrast-Enhanced Harmonic Endoscopic Ultrasound |
| 臺大學術典藏 |
2022-02-14T05:27:17Z |
Defining the endoscopic ultrasound features of chronic pancreatitis in Asians: A multicenter validation study
|
Koh C.J.; Lakhtakia S.; Kida M.; Lesmana C.R.A.; Ang T.L.; Vu C.K.F.; Aye T.T.; Park S.H.; Almadi M.A.; Chong C.C.-N.; Tang R.S.Y.; Wu X.; Hilmi I.; Dhir V.; Pausawasdi N.; Basha J.; Jin Z.-D.; Yang A.M.; Teoh A.Y.B.; Seo D.-W.; HSIU-PO WANG; Ho K.Y. |
| 臺大學術典藏 |
2022-02-14T05:27:17Z |
Endoscopic ultrasound ablation in a patient with multiple metastatic pancreatic tumors from adrenocorticotropic hormone-producing thymic neuroendocrine neoplasm
|
Chang L.-K.; Chen K.-C.; Cheng M.-F.; Lin C.-C.; HSIU-PO WANG; Sung C.-T.; Chen J.-H.; Yen R.-F.; Hsu C.-L.; Shih S.-R. |
| 臺大學術典藏 |
2022-02-14T05:27:17Z |
Clinical efficacy and safety of peroral endoscopic myotomy for esophageal achalasia: A multicenter study in Taiwan
|
Shieh T.-Y.; Chen C.-C.; Chou C.-K.; Hu T.-Y.; Wu J.-F.; Chen M.-J.; HSIU-PO WANG; Wu M.-S.; Tseng P.-H. |
| 臺大學術典藏 |
2022-02-14T05:27:18Z |
Assessment of tumor extension to the ductal system of submucosal glands in patients with superficial esophageal squamous neoplasms: Implications for endoscopic resection
|
Wang W.-L.; Chang I.-W.; Moi S.-H.; Hsu M.-H.; Chen C.-J.; Hsu C.-T.; HSIU-PO WANG; Lee C.-T. |
| 臺大學術典藏 |
2022-02-14T05:27:18Z |
Anatomical and physiological characteristics in patients with Laryngopharyngeal Reflux Symptoms: A case-control study utilizing high-resolution impedance manometry
|
Tseng W.-H.; Hsu W.-C.; Hsiao T.-Y.; Wu J.-F.; Lee H.-C.; HSIU-PO WANG; Wu M.-S.; Tseng P.-H. |
| 臺大學術典藏 |
2022-02-14T05:27:18Z |
New-generation endocytoscopy with CM double staining for optical characterization of colon sessile serrated adenoma
|
Wang W.-L.; HSIU-PO WANG; Han M.-L.; Lee C.-T. |
| 臺大學術典藏 |
2022-02-14T05:35:11Z |
miR-155-regulated mTOR and Toll-like receptor 5 in gastric diffuse large B-cell lymphoma
|
Huang, Wei-Ting; Kuo, Sung-Hsin; Kuo, Yi-Chun; CHUNG-WU LIN |
| 臺大學術典藏 |
2022-02-14T05:35:58Z |
Achalasia: An Update
|
Tsai, Feng Pai; Huang, Chun Fu; Wu, Chia Hao; CHIEN-CHUAN CHEN; HSIU-PO WANG; PING-HUEI TSENG |
| 臺大學術典藏 |
2022-02-14T05:41:56Z |
Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003
|
Tseng W.-P.; Wu, Jhong-Lin; Wu, Chen-Chi; KUAN-TING KUO; Lin C.-H.; Chung, Ming-Yi; Lee, Ya-Fan; Yang, Bey-Jing; Huang, Chien-Hua; Chen, Shey-Ying; Yu, Chong-Jen; Chen, Shyr-Chyr; Hsueh, Po-Ren |
| 臺大學術典藏 |
2022-02-14T05:43:01Z |
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
|
Lin, Ching-Hung; Huang, Ruby Yun-Ju; Lu, Tzu-Pin; KUAN-TING KUO; Lo, Ko-Yun; Chen, Ching-Hsuan; Chen, I-Chun; Lu, Yen-Shen; Chuang, Eric Y; Thiery, Jean Paul; Huang, Chiun-Sheng; Cheng, Ann-Lii |
| 臺大學術典藏 |
2022-02-14T06:28:41Z |
The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double-blind, placebo-controlled, randomized trial
|
Chen M.-J.; Chen C.-C.; Huang Y.-C.; Tseng C.-C.; Hsu J.-T.; Lin Y.-F.; YU-JEN FANG; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease, Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline Results
|
Lee Y.-C.; Chiang T.-H.; Chiu H.-M.; Wu M.-S.; Yeh Y.-P.; Hsiu-Hsi Chen T.; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; YU-JEN FANG; Chan C.-C.; Collaborators of the Taiwan Community-Based Integrated Screening Group |
| 臺大學術典藏 |
2022-02-14T06:28:43Z |
Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles
|
Chen C.-C.; Wu W.-K.; Chang C.-M.; Panyod S.; Lu T.-P.; Liou J.-M.; YU-JEN FANG; Chuang E.Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:43Z |
Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis
|
Liu C.-H.; Peng C.-Y.; YU-JEN FANG; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:44Z |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Chen M.-J.; YU-JEN FANG; Wu M.-S.; Chen C.-C.; Chen Y.-N.; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:44Z |
Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in Taiwan
|
Yang T.-H.; YU-JEN FANG; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Chen C.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:44Z |
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan
|
YU-JEN FANG; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; Wu M.-S.; Luo J.-C.; Liou J.-M. |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
|
Chen C.-C.; Luo J.-C.; YU-JEN FANG; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-M.; YU-JEN FANG; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; YU-JEN FANG; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:47Z |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; YU-JEN FANG; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; YU-JEN FANG; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection
|
Chen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; YU-JEN FANG; Lin J.-T.; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:48Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; YU-JEN FANG; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection
|
Liu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:49Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; YU-JEN FANG; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:50Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; YU-JEN FANG; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
YU-JEN FANG; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:51Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; YU-JEN FANG; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2022-02-14T06:28:52Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; YU-JEN FANG; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S. |
| 臺大學術典藏 |
2022-02-14T06:28:53Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; YU-JEN FANG; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameter
|
Han M.-L.; Lee Y.-C.; Chen C.-C.; YU-JEN FANG; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors
|
YU-JEN FANG; Cheng T.-Y.; Sun M.-S.; Yang C.-S.; Chen J.-H.; Liao W.-C.; Wang H.-P. |
| 臺大學術典藏 |
2022-02-14T06:28:54Z |
Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma
|
Yang S.-H.; Lin L.-W.; YU-JEN FANG; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:55Z |
Barium appendicitis
|
YU-JEN FANG; Wang H.-P.; Ho C.-M.; Liu K.-L. |
